HomeAI · summaries
Storia in 7 fonti
Eli Lilly's obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop
Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight loss and diabetes drugs.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
wired.com
Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results
In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.
- ·
cnbc.com
Eli Lilly's obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop
Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight loss and diabetes drugs.
- ·
telegraph.co.uk
Ozempic-style pill can help people lose two stone
Eli Lilly’s orforglipron could offer needle-free alternative to weight-loss jabs at lower cost
- ·
bbc.com
Daily weight loss pill helps patients lose 12% of body weight
Trials of a daily obesity pill showed patients lost about 12% of their body weight over 72 weeks.
- ·
theguardian.com
Daily pill helps patients lose 12% of body weight in early trial
Results of study suggest orforglipron could be a simpler, cheaper alternative to injections
- ·
sueddeutsche.de
Eli Lilly: Erste klinische Daten zur Abnehmpille Orforglipron bekannt
Eli Lilly präsentiert erste Ergebnisse zur Abnehmpille Orforglipron. In einer Phase-III-Studie zeigten sich signifikante Gewichtsverluste.
- ·
upi.com
Initial results show promise for Eli Lilly's new weight loss drug - UPI.com
Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.